GlassScriptPhysician profile
Justin Walsh
NPI 1750030953
$1,536.54
in general payments reported to CMS, 2019-2025
9 companies · $912 in 2025
The $912 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $347 · 2023: $218 · 2024: $60.31 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $671.07 | 2022-2025 | Infinity Adaptis, Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Pacira Pharmaceuticals Incorporated | $331.54 | 2022-2023 | Iovera, Exparel |
| Carlsmed, INC. | $185.01 | 2022 | |
| Heron Therapeutics, INC. | $96.34 | 2025 | Zynrelef |
| Medinc of Texas | $84.51 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $75.29 | 2025 | G7 |
| Vertex Pharmaceuticals Incorporated | $49.79 | 2025 | |
| Innovation Technologies INC | $26.90 | 2023 | Irrisept |
| Ethicon US, LLC | $16.09 | 2024 | Ethicon, Stratafix, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.